Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
OPERATING ACTIVITIES:
Net loss	$ (530,873)	$ (3,725,027)
Loss from discontinued operations	(384,345)	(392,177)
Net loss from continuing operations	(146,528)	(3,332,850)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	70,488	47,353
Stock-based compensation	60,667	436,349
Compensation warrants	0	231,335
Amortization of debt discount and beneficial conversion feature	356,340	776,122
Debt default penalty	0	286,059
Loss on modification of line of credit	0	650,000
Gain on extinguishment	(22,405)	(467,872)
Gain on settlement of accounts payable	0	(422,414)
Loss on disposal of assets	15,639	0
Loss on impairment of note receivable	3,025,000	0
Gain on deconsolidation	(5,206,208)	0
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	162,318	(237,475)
Accounts payable	821,253	(248,115)
Accrued expenses	(948,319)	166,828
Accrued interest	118,286	549,703
Indebtedness to related parties	(84,913)	(501,599)
Net cash used in operating activities of continuing operations	(1,778,382)	(2,066,576)
Net cash used in operating activities of discontinued operations	(87,772)	(118,644)
Net cash used in operating activities	(1,866,154)	(2,185,220)
INVESTING ACTIVITIES:
Proceeds from sale of Nevada Subsidiaries	1,648,772	0
Proceeds of note receivable	0	5,051,923
Acquisition of intangible assets	(200,000)	(292,675)
Net cash provided by investing activities of continuing operations	1,448,772	4,759,248
Net cash provided by/(used in) investing activities of discontinued operations	1,567	(103,729)
Net cash provided by investing activities	1,450,339	4,655,519
FINANCING ACTIVITIES:
Proceeds from warrant exercises	138,728	1,075,396
Proceeds from convertible notes payable	50,000	725,000
Proceeds from line of credit	0	375,000
Principal payment on notes payable	(575,000)	(3,156,014)
Principal payment on related party note	0	(151,923)
Brokerage fees from warrant exercises and stock issuances	(6,266)	(107,373)
Fees for issuance of convertible notes	0	(74,750)
Net cash used in financing activities of continuing operations	(392,538)	(1,314,664)
Net cash used in financing activities of discontinued operations	(103,387)	(161,768)
Net cash used in financing activities	(495,925)	(1,476,432)
NET CHANGE IN CASH AND CASH EQUIVALENTS	(911,740)	993,867
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR	1,145,633	151,766
CASH AND CASH EQUIVALENTS AT END OF YEAR	233,893	1,145,633
Less: cash and cash equivalents classified as discontinued operations	0	(352,593)
CASH AND CASH EQUIVALENTS AT END OF YEAR FROM CONTINUING OPERATIONS	233,893	793,040
Cash paid for interest	0	241,014
Cash paid for income tax	0	0
Noncash investing and financing transactions:
Note receivable from sale of Nevada Subsidiaries	3,025,000	0
Extinguishment of debt and accrued interest owed to purchasers of Nevada Subsidiaries and purchasers' affiliates	2,612,854	0
Extinguishment of accrued management fees payable to purchaser of Nevada Subsidiaries	850,000	0
Accrued liabilities forgiven in connection with Wellcana Note settlement	0	172,500
Depreciation capitalized in inventory (discontinued operations)	349,015	532,785
Accrued interest capitalized in convertible note principal	0	223,094
Patent acquisition costs capitalized in intangible assets	347,617	319,939
Stock options issued for preparing capitalized patent applications	28,800	168,000
Stock issued upon conversion of notes payable	0	160,000
Inducement dividend from warrant exercises	163,017	2,774,000
Convertible Notes Payable [Member]
Noncash investing and financing transactions:
Beneficial conversion feature on notes payable	$ 0	$ 543,886